Are you an adult suffering from a long-standing cough that does not produce phlegm and stops as soon as you fall asleep? Has your cough failed to improve despite being treated with different ...

Researchers found that adults with chronic cough reported lower quality of life, greater health care resource utilization, and reduced work productivity than those without it. Researchers estimated ...

GSK (GSK) shares fell in London on Friday after the British drugmaker announced it will not advance camlipixant, an experimental cough therapy added in 2023 through its Bellus Health acquisition, ...

Background and Objective: Chronic cough is the most common medical problem for patients presenting to primary and secondary health care bringing a significant disease burden. Asia has the largest ...

Chronic cough, with symptoms lasting more than eight weeks, affects approximately one in 10 adults. Cough is among the most common reasons for seeking medical care in the United States, yet chronic ...

GSK shares fell after the U.K. drugmaker said it would stop working on an experimental treatment for chronic cough after ...

For patients with type 2 diabetes, there is an association between glucagon-like peptide-1 receptor agonist (GLP-1 RA) use and chronic cough, according to a study published online Nov. 26 in JAMA ...

Three years after buying Bellus Health and its chronic cough candidate camlipixant for around $2 billion, GSK is abandoning ...

A devastating respiratory infection once thought to be primarily a childhood concern is making an alarming comeback among adults, catching the medical community and patients completely off guard.

Those prescribed a GLP-1 RA had a significantly increased risk for new chronic cough compared with those prescribed any non-GLP-1 RA second-line medication, DPP-4 inhibitor, or sulfonylurea in a ...

Association persisted after removing patients with previous diagnosis of gastroesophageal reflux. (HealthDay News) — For patients with type 2 diabetes, there is an association between glucagon-like ...